RxDoctor Payments DataLook up a doctor →

Salima Brillman

Psychiatry · Sunnyvale, CANPI 1841292455

Payments from drug & device makers

$1,536,685in general payments, 2019–2025

Across 1,657 payments — averaging $927.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MDD US Operations, LLC$405K
  • Amneal Pharmaceuticals LLC$250K
  • AbbVie$151K
  • Neurocrine Biosciences, Inc.$139K
  • Teva Pharmaceuticals USA, Inc.$122K
  • Acorda Therapeutics, Inc$99K
  • plus $371K from 24 others
$146,140in research payments, 2019–2025

Across 16 payments — averaging $9133.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amneal Pharmaceuticals LLC$138K
  • Acadia Pharmaceuticals Inc$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,536,685 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Sunnyvale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →